Markov Modelling of Mitochondrial BAK Activation Kinetics during Apoptosis

  • C. Grills
  • D. A. Fennell
  • S. F. C. Shearer
Part of the Lecture Notes in Computer Science book series (LNCS, volume 5792)

Abstract

The molecular mechanism underlying mitochondrial BAK activation during apoptosis remains highly controversial. Two seemingly conflicting models known as the agonism model and the de-repressor model have been proposed. In the agonism model, BAK requires activator BH3 only proteins to initiate a series of events that results in cell apoptosis. In the de-repressor model the antagonism of pro-survival BCL-2 family proteins alone is sufficient for BAK activation kinetics to promote apoptosis. To gain a better understanding of the kinetic implications of these models and reconcile these opposing, but highly evidence-based theories, we have formulated Markov chain models which capture the molecular mechanisms underlying both the agonism and de-repressor models. Our results indicate that both pure agonism and dissociation are mutually exclusive mechanisms capable of initiating mitochondrial apoptosis by BAK activation.

Keywords

BAK activation kinetics apoptosis BH3-only proteins BCL-2 family proteins agonism model derepressor model 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adams, J.M., Cory, S.: The bcl-2 protein family: arbiters of cell survival. Science 281, 1322–1326 (1998)CrossRefGoogle Scholar
  2. 2.
    Letai, A., et al.: Pharmacological manipulation of bcl-2 family members to control cell death. J. Clin. Invet. 115, 2648–2655 (2005)CrossRefGoogle Scholar
  3. 3.
    Green, D.R.: Apoptotic pathways: ten minutes to dead. Cell 121, 671–674 (2005)CrossRefGoogle Scholar
  4. 4.
    Scorrano, L., Korsmeyer, S.J.: Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochemical and Biophysical Research Communications 304, 437–444 (2003)CrossRefGoogle Scholar
  5. 5.
    Walensky, L.D., Pitter, K., Morash, J., Oh, K.J., Barbuto, S., et al.: A stapled BID BH3 helix directly binds and activates BAX. Mol. Cell 24(2), 199–210 (2006)CrossRefGoogle Scholar
  6. 6.
    Cheng, E.H., et al.: Bcl-2, Bcl-Xl sequestered BH3 domain only molecules preventing bax and Bak mediated mitochondrial apoptosis. Mol. Cell 8, 705–711 (2001)CrossRefGoogle Scholar
  7. 7.
    Grills, C., Crawford, N., Chacko, A., Johnston, P.G., O’Rourke, S.F.C., Fennell, D.A.: Dynamical systems analysis of mitochondrial BAK activativation kinetics predicts resistance to BH3 domains. PLoS ONE 3(8), 30–38 (2008)CrossRefGoogle Scholar
  8. 8.
    Oltersdorf, T., Elmore, S.W., Shoemaker, A.R., Armstrong, R.C., Augeri, D.J., et al.: An inhibitor of bcl-2 family proteins induces regression of solid tumours. Nature 435(7042), 677–681 (2005)CrossRefGoogle Scholar
  9. 9.
    Walensky, L.D., Kung, A.L., Escher, I., Malia, T.J., Barbuto, S., et al.: Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 305(5689), 1466–1470 (2004)CrossRefGoogle Scholar
  10. 10.
    Chen, C., Cui, J., Lu, H., Wang, R., Zhang, S., et al.: Modeling of the role of a bax-activation switch in the mitochondrial apoptosis decision. Biophys. Journal 92(12), 4304–4315 (2007)CrossRefGoogle Scholar
  11. 11.
    Ghosh, S., Ghosh, P., Basu, K., Das, S., et al.: Modeling the stochastic dynamics of gene expression in single cells: A birth and death markov chain analysis. In: IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, Los Alamitos (2007)Google Scholar
  12. 12.
    Asavathiratham, C., Roy, S., Lesieutre, B., Verghese, G.: The influence model. Control systems Magazine. IEEE 21(6), 52–64 (2001)Google Scholar
  13. 13.
    Gillespie, D.T.: Exact stochastic simulation of coupled chemical reactions. J. Phys. Chem. 81, 2340–2361 (1977)CrossRefGoogle Scholar
  14. 14.
    Stirzaker, D.: Stochastic Processes and Models. Oxford University Press, Oxford (2005)MATHGoogle Scholar
  15. 15.
    Rudden, R.: Cancer Biology, 3rd edn. Oxford University Press, Oxford (1995)Google Scholar
  16. 16.
  17. 17.
    Willis, S.N., Fletcher, J.I., Kaufmann, T., van Delft, M.F., Chen, L., et al.: Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315(5813), 856–859 (2007)CrossRefGoogle Scholar
  18. 18.
    Ruffolo, S.C., Shore, G.C.: BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization. J. Biol. Chem. 278(27), 25039–25045 (2003)CrossRefGoogle Scholar
  19. 19.
    Falcke, M.: Deterministic and stochastic models of intracellular Ca2+ waves. New Journal of Physics 5, 96.1–96.28 (2003)Google Scholar
  20. 20.
    Kitano, H.: Computational systems biology. Nature 420, 206–210 (2002)CrossRefGoogle Scholar
  21. 21.
    Gonze, D., Halloy, J., Goldbeter, A.: Deterministic versus stochastic models for circadian rhythms. J. Biol. Phys. 28, 637–653 (2002)CrossRefGoogle Scholar
  22. 22.
    Srivastava, R., You, L., Summers, J., Yin, J.: Stochastic versus deterministic modeling of intracellular viral kinetics. J. Theor. Biol. 218, 309–321 (2002)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • C. Grills
    • 1
  • D. A. Fennell
    • 1
  • S. F. C. Shearer
    • 1
  1. 1.Centre for Cancer Research and Cell BiologyQueen’s UniversityBelfastN. Ireland

Personalised recommendations